LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer

A set of prostate tumors tend to grow slowly and do not require active treatment. Therefore, stratification between patients with clinically significant and clinically insignificant prostate cancer (PC) remains a vital issue to avoid overtreatment. Fast development of genetic technologies accelerate...

Descripción completa

Detalles Bibliográficos
Autores principales: Vezelis, Alvydas, Simiene, Julija, Dabkeviciene, Daiva, Kincius, Marius, Ulys, Albertas, Suziedelis, Kestutis, Jarmalaite, Sonata, Jankevicius, Feliksas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803409/
https://www.ncbi.nlm.nih.gov/pubmed/33488712
http://dx.doi.org/10.1155/2021/8820366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803409/
https://www.ncbi.nlm.nih.gov/pubmed/33488712
http://dx.doi.org/10.1155/2021/8820366

Ejemplares similares